Penicillin Active Pharmaceutical Ingredients Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

Pencillin Active Pharmaceutical Ingredients Market

The global Penicillin Active Pharmaceutical Ingredients market was valued at US$ 1948.4 million in 2020 and is expected to reach US$ 1681 million by the end of 2027, growing at a CAGR of -1.4% during 2021-2027.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-20Q8958/Global_Penicillin_Active_Pharmaceutical_Ingredients_Market_Outlook_2022

Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. It is an antibiotic extracted from Penicillium. Penicillin belongs to β-lactam antibiotics, and β-lactam antibiotics include penicillin, cephalosporin, carbapenems, monocyclic, and cephalosporins. Penicillin is a very common antibacterial drug. However, an intradermal test must be performed before each use to prevent allergies.

Pencillin Active Pharmaceutical Ingredients Market Share

Global key players of Penicillin Active Pharmaceutical Ingredients include United Laboratories, Changsheng Pharma, North China Pharmaceutical, Centrient Pharmaceuticals, Aurobindo Pharma and Sinopharm Weiqida Pharmaceutical, etc. Top five players occupy for a share about 50%. Asia-Pacific is the largest market, with a share about 60%, followed by Americas and Europe. In terms of product, Amoxicillin is the largest segment, with a share over 76%. In terms of application, For Oral is the largest market, with a share over 73%.

This report focuses on Penicillin Active Pharmaceutical Ingredients volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Penicillin Active Pharmaceutical Ingredients market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Type
• Amoxicillin
• Piperacillin
• Benzylpenicillin Sodium
• Ampicillin
• Other

By Application
• For Oral
• For Injection

By Company
• Centrient Pharmaceuticals
• Jiangxi Fushine Pharmaceutical
• Kelun
• Harbin Pharmaceutical Group
• Changzhou RedSun
• Jiangxi Huabang
• LKPC
• Huaxing Pharma
• North China Pharmaceutical
• Qilu Tianhe Pharma
• Novartis (Sandoz Anti-Infectives)
• CSPC Zhongrun
• United Laboratories
• Sinopharm Weiqida Pharmaceutical
• Changsheng Pharma
• Aurobindo Pharma
• Novartis
• ACS Dobfar

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-20Q8958/global-penicillin-active-pharmaceutical-ingredients

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.